Cystic Fibrosis Care Still Below Pre-Pandemic Levels
New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019 levels despite new treatments and telehealth options.
New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019 levels despite new treatments and telehealth options.
Research using lung-on-a-chip technology shows that mechanical stress from asthma attacks causes tissue damage independently of inflammation.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
New research suggests cystic fibrosis transmembrane conductance regulator (CFTR) modulators may provide mental health benefits for pediatric patients and their caregivers early in treatment.
Molecular diagnostics provide faster, more accurate identification of mucormycosis and co-infections compared to traditional culture methods.
Rextovy, a 4 mg naloxone medication, will be available for purchase without a prescription at retail stores and online.
The minimally invasive surgical approach may allow high-risk or frail patients to become candidates for lung transplantation.
The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.